BTG vein treatment on track for potential 2014 launch

03:38 EDT 12 Apr 2013 | Reuters

LONDON (Reuters) - BTG's Varisolve treatment for varicose veins has been accepted for review by the U.S. Food and Drug Administration, putting it on track for potential approval and launch during the first half of 2014.

Original Article: BTG vein treatment on track for potential 2014 launch

NEXT ARTICLE

More From BioPortfolio on "BTG vein treatment on track for potential 2014 launch"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story